Clinical and biochemical evaluation of Rituximab as add on therapy in Neuromyelitis Optica Spectrum Disorders,International Journal of Neuroscience

当前位置： X-MOL 学术 › Int. J. Neurosci. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Clinical and biochemical evaluation of Rituximab as add on therapy in Neuromyelitis Optica Spectrum Disorders
International Journal of Neuroscience ( IF 2.2 ) Pub Date : 2024-04-01 , DOI: 10.1080/00207454.2024.2338255
Chawen Ding ₁ , Lei Zheng ₁ , Mingjian Xiong ₁ , Dongping Zhang ₁ , Zhongmei Chen ₁ , Linge Wang ₁ , Zhihua Luo ₁ , Hong Qiao ₂

Affiliation

Objective: This study assesses the efficacy of rituximab in the treatment of neuromyelitis optica spectrum disorders (NMOSD).Methods: The study initially included 40 patients with NMOSD diagnosed, ...

中文翻译：